AMGEN INC - AMGN

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$146.2B
QoQ value delta ($000)
+$26.26B (+21.9%)
Implied price effect (QoQ)
+15.95%
Shares
Total shares
446,881,529
QoQ shares delta
+21,813,611 (+5.13%)
Total shares held by funds (by quarter)

Market chart (AMGN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 20 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 17,949,296 54,838,826 0.26%
BlackRock, Inc. 15,513,229 47,396,138 0.26%
STATE STREET CORP 10,012,872 30,591,403 0.34%
Capital World Investors 7,560,249 23,097,711 1.03%
Capital International Investors 5,952,964 18,186,270 0.93%
MORGAN STANLEY 5,153,342 15,744,528 0.31%
GEODE CAPITAL MANAGEMENT, LLC 4,665,822 14,303,294 0.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3,865,873 11,811,045 0.6%
PRIMECAP MANAGEMENT CO/CA/ 2,914,688 8,904,979 2.21%
WELLS FARGO & COMPANY/MN 2,328,088 7,112,793 0.42%
NORGES BANK 2,164,162 6,611,965 0.23%
NORTHERN TRUST CORP 2,023,318 6,181,658 0.26%
BANK OF AMERICA CORP /DE/ 1,812,433 5,537,361 0.13%
Invesco Ltd. 1,567,310 4,788,460 0.24%
ROYAL BANK OF CANADA 1,540,624 4,706,930 0.25%
Capital Research Global Investors 1,521,390 4,648,155 0.28%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1,506,941 4,604,019 0.32%
GOLDMAN SACHS GROUP INC 1,505,743 4,600,358 0.18%
UBS Group AG 1,368,126 4,179,912 0.22%
Bank of New York Mellon Corp 1,278,805 3,907,016 0.23%
Legal & General Group Plc 1,247,526 3,811,451 0.28%
FMR LLC 1,175,769 3,592,220 0.06%
Amundi 1,111,854 3,396,945 0.3%
Aristotle Capital Management, LLC 1,077,711 3,292,564 2.16%
DIMENSIONAL FUND ADVISORS LP 1,057,561 3,230,979 0.22%